ArticleMedicine2026
The causal relationship between neuroimaging and Parkinson's disease: A two-sample Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder whose etiology and progression remain not fully understood, posing significant challenges for both diagnosis and treatment. This study leverages the 2-sample Mendelian Randomization (TSMR) approach to systematically examine the possible causal connections involving neuroimaging characteristics and the risk of developing PD. Making use of genetic variations from extensive genome-wide association studies (GWAS) as instrumental factors, this analysis focuses on neuroimaging traits related to cortical and subcortical gray matter volumes. The primary findings reveal that specific changes in neuroimaging traits, notably in regions such as the right ventral diencephalon and the thalamus, have a strong causal connection with the risk of PD. These associations were robust across multiple MR methods, including MR-Egger, Inverse-Variance Weighted (IVW), and Weighted Median approaches, supplemented by extensive sensitivity analyses to guarantee the accuracy of the findings. Our research's insights into the structural and functional brain changes provide a deeper understanding of PD's etiology, suggesting that certain neuroimaging features may not only precede but also potentially drive the disease process. This underscores the possibility of these neuroimaging traits serving as early biomarkers or targets for preventive measures against PD. Despite its strengths in causal inference and the use of extensive GWAS datasets, limitations include reliance on data primarily from European populations and inherent assumptions of Mendelian Randomization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.